Majid Zeidi

United States Department of Veterans Affairs

Also affiliated with SUNY Downstate Health Sciences University, Philadelphia VA Medical Center, University of Pennsylvania

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial”.

Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial

Journal of Investigative Dermatology(2022)10.1016/j.jid.2022.03.029

N/A

0.601DataRank · unranked

54 citations

Emily Z. Hejazi, S.M. Peña, Jessica S. Haber, Majid Zeidi, Nithin Reddy +10 more

The effects of immunostimulatory herbal supplements on autoimmune skin diseases

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.06.037

N/A

0DataRank · unranked

41 citations

Srita Chakka, Josef Symon S. Concha, Majid Zeidi, Victoria P. Werth, Christina E. Bax

Myeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness

Journal of Investigative Dermatology(2021)10.1016/j.jid.2020.12.032

N/A

0DataRank · unranked

31 citations

Jay Patel, Majid Zeidi, Maria Wysocka, Muhammad M. Bashir, Basil Patel +4 more